- Home
- PX vs BLFS Comparison
PX vs BLFS Comparison
Compare PX & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PX
- BLFS
- Stock Information
- Founded
- PX 1992
- BLFS 1987
- Country
- PX United States
- BLFS United States
- Employees
- PX N/A
- BLFS N/A
- Industry
- PX Investment Managers
- BLFS Medical/Dental Instruments
- Sector
- PX Finance
- BLFS Health Care
- Exchange
- PX Nasdaq
- BLFS Nasdaq
- Market Cap
- PX 1.0B
- BLFS 1.0B
- IPO Year
- PX 2021
- BLFS 1989
- Fundamental
- Price
- PX $10.84
- BLFS $21.89
- Analyst Decision
- PX Buy
- BLFS Strong Buy
- Analyst Count
- PX 8
- BLFS 7
- Target Price
- PX $14.19
- BLFS $30.57
- AVG Volume (30 Days)
- PX 1.2M
- BLFS 565.6K
- Earning Date
- PX 08-07-2025
- BLFS 08-07-2025
- Dividend Yield
- PX 1.36%
- BLFS N/A
- EPS Growth
- PX N/A
- BLFS N/A
- EPS
- PX 0.16
- BLFS N/A
- Revenue
- PX $298,000,000.00
- BLFS $87,762,000.00
- Revenue This Year
- PX $1.88
- BLFS $21.21
- Revenue Next Year
- PX $17.29
- BLFS $17.58
- P/E Ratio
- PX $66.34
- BLFS N/A
- Revenue Growth
- PX 18.92
- BLFS 34.80
- 52 Week Low
- PX $8.57
- BLFS $18.70
- 52 Week High
- PX $14.28
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- PX 58.96
- BLFS 48.56
- Support Level
- PX $10.43
- BLFS $21.91
- Resistance Level
- PX $11.07
- BLFS $23.25
- Average True Range (ATR)
- PX 0.34
- BLFS 0.91
- MACD
- PX 0.17
- BLFS 0.09
- Stochastic Oscillator
- PX 89.84
- BLFS 54.40
About PX P10 Inc.
P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.